Pharmaceutical Industry Trends & News - Pharmaceutical Technology

News

Sanofi and Regeneron expand immunology partnership to the tune of $8bn

The agreement will see Sanofi and Regeneron co-develop and co-commercialise four long-lasting antibodies.

Robert Barrie

News

Varda pockets $251m to back space-based pharma processing mission

Annabel Kartal Allen

News

Atossa plans shareholder stake in potential PRV proceeds

Robert Barrie

News

Bristol Myers Squibb secures expanded US approval for Camzyos

News

BioMarin and Profluent partner on AI-designed enzyme therapies

News

OBIO marks $704m funding milestone for Canadian health tech ventures

PremiumAnalyst Comment

EASD 2026: Orforglipron shows an efficacy edge over oral semaglutide in T2D

News

Kyowa Kirin, Knight agree Latin American distribution deal for mogamulizumab

Analysis

PremiumAnalyst Comment

EASD 2026: Tirzepatide outperforms semaglutide in real-world type 2 diabetes analysis

GlobalData Healthcare

PremiumAnalyst Comment

EASD 2026: CagriSema weight loss holds at submaximal doses in REDEFINE-1 analysis

GlobalData Healthcare

PremiumAnalyst Comment

China expands its manufacturing role for biopharma’s new drugs

GlobalData Healthcare

Features

Podcast: How Sandoz plans to harness its “golden decade”

Robert Barrie

Themes

Partner Content

Drug delivery’s next bottleneck isn’t innovation, it’s industrial capacity

Surging demand for injectable therapies (led by GLP‑1s) is exposing a new constraint in drug delivery: not innovation, but the ability to industrialise and manufacture devices at scale.

More themes

News

Australia starts investigation into OpenAI Medicare breach

Partner Content

How DFE Pharma supports confident continuous manufacturing decisions

Partner Content

Industry partnership will determine the success of the transition to low-GWP pMDIs

News

Bristol Myers, NVIDIA join forces to build life science’s ‘most powerful’ AI factory

Data Insights

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...

Data Insights

Leading clinical trials companies in the artificial intelligence theme

Data Insights

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

Data Insights

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

More Insights

Buyer's Guides

Buyer's Guides

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Buyer's Guides

Leading artificial intelligence (AI) companies in pharma

Buyer's Guides

Leading strategic intelligence solutions for the pharmaceutical industry

Buyer's Guides

Key lead generation providers and technology solutions for the pharmaceutical industry

GlobalData Reports

Rare Diseases: Innovation, Investment, and Unmet Needs - Strategic Intelligence

$3450.00

Bio/Pharmaceutical Outsourcing Report, August 2026

$2950.00

Small-Cell Lung Cancer (SCLC): Market View, Current and Future Competitive Landscape

$3495.00

Hodgkin Lymphoma: Epidemiology Report and Forecast

$9995.00

Glioblastoma (GBM): Epidemiology Report and Forecast, 2026

$9995.00

Digital Magazine

Latest Issue

Pharma Technology Focus

Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.

Sections

Sections

Sections

Sections

Sections

Sections

Varda pockets $251m to back space-based pharma processing mission

Atossa plans shareholder stake in potential PRV proceeds

Bristol Myers Squibb secures expanded US approval for Camzyos

BioMarin and Profluent partner on AI-designed enzyme therapies

OBIO marks $704m funding milestone for Canadian health tech ventures

EASD 2026: Orforglipron shows an efficacy edge over oral semaglutide in T2D

Kyowa Kirin, Knight agree Latin American distribution deal for mogamulizumab

EASD 2026: Tirzepatide outperforms semaglutide in real-world type 2 diabetes analysis

EASD 2026: CagriSema weight loss holds at submaximal doses in REDEFINE-1 analysis

China expands its manufacturing role for biopharma’s new drugs

Podcast: How Sandoz plans to harness its “golden decade”

Drug delivery’s next bottleneck isn’t innovation, it’s industrial capacity

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

Accelerate decision-making with data-led confidence

Leading clinical trials companies in the artificial intelligence theme

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Leading artificial intelligence (AI) companies in pharma

Leading strategic intelligence solutions for the pharmaceutical industry

Key lead generation providers and technology solutions for the pharmaceutical industry

Rare Diseases: Innovation, Investment, and Unmet Needs - Strategic Intelligence

Bio/Pharmaceutical Outsourcing Report, August 2026

Small-Cell Lung Cancer (SCLC): Market View, Current and Future Competitive Landscape

Hodgkin Lymphoma: Epidemiology Report and Forecast

Glioblastoma (GBM): Epidemiology Report and Forecast, 2026

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.

More themes

Accelerate decision-making with data-led confidence

More Insights

Rare Diseases: Innovation, Investment, and Unmet Needs - Strategic Intelligence

Bio/Pharmaceutical Outsourcing Report, August 2026

Small-Cell Lung Cancer (SCLC): Market View, Current and Future Competitive Landscape

Hodgkin Lymphoma: Epidemiology Report and Forecast

Glioblastoma (GBM): Epidemiology Report and Forecast, 2026

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing